Naslov: | Cathepsin D and plasminogen activator inhibitor type 1 in normal, benign and alignant ovarian tissues : a preliminary report |
---|
Avtorji: | ID Šprem, Marina (Avtor) ID Babić, Damir (Avtor) ID Abramić, Marija (Avtor) ID Miličić, Duško (Avtor) ID Vrhovec, Ivan (Avtor) ID Škrk, Janez (Avtor) ID Osmak, Maja (Avtor) |
Datoteke: | PDF - Predstavitvena datoteka, prenos (442,49 KB) MD5: 1C6BCCFA14ADF6A5E13A441CC7CB3C8B
|
---|
Jezik: | Angleški jezik |
---|
Tipologija: | 1.01 - Izvirni znanstveni članek |
---|
Organizacija: | OI - Onkološki inštitut Ljubljana
|
---|
Povzetek: | Background. The aim of the present study was to determine the concentration ofcathepsin D (Cath D) and plasminogen activator inhibitor type 1 (PAI-1) in normal ovarian tissues, benign and malignant ovarian tumor tissues, and to asses relationship between Cath D and PAI-1 content, and some clinical and pathohistological parameters. Materials and methods. Cath D contents and PAI-1concentrations were determined (using immunoradiometric ELSA-Cath D assayand commercial IMUDIND R ELISA immunoassay, respectively) in 35 samples: 10 normal ovarii, 10 benign, 10 primary malignant and 5 metastatic ovarian tumors. Results. The concentrations of Cath D were significantly higher in malignant (32.89+-14.26 pmol/mg protein ) and metastatic (31.42+-10.24 pmol/mgprotein), than in normal (13.68+-4.03 pmol/mg protein) and benign (17.89+-13.13 pmol/mg protein) ovarian tissues. There was no statistical differences in the concentrations of PAI-1 between normal, benign, malignant and metastatic tumor specimens. The concentrations of Cath D as well as PAI-1 did not correlate to the age of patients, menopausal status, parity, GOG risk group, clinical stage or pathohistological grading. Conclusion. Concentrationsof Cath D (but not PAI-1) were significantly increased in malignant and metastatic ovarian tumor tissues when compared to normal and benign ovarian tumor samples; they were independent from pathohistological andclinical parameters. |
---|
Status publikacije: | Objavljeno |
---|
Verzija publikacije: | Objavljena publikacija |
---|
Datum objave: | 01.03.2000 |
---|
Založnik: | Slovenian Medical Association - Slovenian Association of Radiology, Nuclear Medicine Society, Slovenian Society far Radiotherapy and Oncology, and Slovenian Cancer Society |
---|
Leto izida: | 2000 |
---|
Št. strani: | str. 41-47 |
---|
Številčenje: | Letn. 34, št. 1 |
---|
Izvor: | Ljubljana |
---|
PID: | 20.500.12556/DiRROS-17940 |
---|
UDK: | 616-006 |
---|
ISSN pri članku: | 1318-2099 |
---|
COBISS.SI-ID: | 11320281 |
---|
Avtorske pravice: | by Authors |
---|
Opomba: | BSDOCID51340;
|
---|
Datum objave v DiRROS: | 23.01.2024 |
---|
Število ogledov: | 560 |
---|
Število prenosov: | 131 |
---|
Metapodatki: | |
---|
:
|
Kopiraj citat |
---|
| | | Objavi na: | |
---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |